Today: 20 May 2026
LSEG share price ticks up as FTSE Russell weighs easier FTSE 100 entry for foreign firms
27 January 2026
1 min read

LSEG share price ticks up as FTSE Russell weighs easier FTSE 100 entry for foreign firms

London, Jan 27, 2026, 08:32 GMT — Regular session

  • Shares of London Stock Exchange Group jumped in early trading following the launch of a consultation on “free float” rules by its index division.
  • The group revealed an additional tranche of share buybacks, pushing forward with its capital returns.
  • Investors are eyeing late February for the consultation deadline as well as LSEG’s full-year results.

Shares of London Stock Exchange Group (LSEG.L) ticked up 0.6% to 8,630 pence in early Tuesday trading. The boost came after its FTSE Russell unit proposed adjustments aimed at simplifying the process for foreign companies to enter major UK indices.

This consultation is key since index eligibility influences investor interest. A large number of passive funds follow the FTSE 100 and FTSE 250, so adjusting the rules could expand the range of firms considering a London listing down the line.

For LSEG, this move comes as investors focus on what might boost new listings and trading volumes in the City, while the group intensifies its shift toward subscription-style income streams like data, index licensing, and clearing.

FTSE Russell has suggested lowering the minimum free float—the share portion available for public trading—to 10% for both UK and non-UK incorporated companies in its FTSE UK Index Series. This means cutting the current 25% threshold for non-UK firms. According to a consultation paper, the change wouldn’t have an immediate effect. Responses are open from Jan. 26 to Feb. 26.

Charles Hunt, Peel Hunt’s head of research, praised the development, noting: “Anything that makes London more competitive and attractive to international businesses is a positive.” Financial Times

Separately, LSEG reported purchasing 167,800 shares on Jan. 26, paying between 8,620 and 8,828 pence each, with an average price of 8,690.37 pence. The company plans to cancel these shares.

The stock dropped 2.2% on Monday, closing at 85.78 pounds, underperforming the modest gains seen in the broader FTSE 100, according to MarketWatch data.

Despite Tuesday’s early gains, traders remain skeptical about whether the new rules will actually boost the flow of big international listings — the type that generate hefty fee income for the exchange and ripple through derivatives and index businesses.

But the consultation risks becoming little more than a box-ticking exercise, delivering scant benefits in the short term. FTSE Russell noted in the paper that the real impact hinges on whether eligible companies decide to list in London down the line.

Investors are eyeing Feb. 26 as the next major date, when LSEG will release preliminary results for the year ending Dec. 31, 2025.

Stock Market Today

  • TSX Penny Stocks To Watch In May 2026: Grown Rogue, Atlas Engineered, Namibia Critical Metals
    May 20, 2026, 9:50 AM EDT. Canadian TSX penny stocks attracted attention in May 2026 amid resilient market conditions and upward earnings revisions. Grown Rogue International (CNSX:GRIN) posted US$9.16 million Q1 revenue but a US$2.7 million net loss, while reducing debt and securing a US$3 million equity investment to expand its cannabis operations. Atlas Engineered Products (TSXV:AEP) reported CA$62.64 million revenue for 2025 with widening losses, yet maintained healthy short-term liquidity and obtained CA$4 million funding to develop a robotic truss facility. The firm is also eyeing Canadian acquisitions in its sector. Both firms are unprofitable but supported by strategic growth initiatives amidst evolving market dynamics. This snapshot underscores how select TSX penny stocks could offer potential for investors willing to engage higher-risk, smaller-cap opportunities.

Latest articles

ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
AmpliTech Jumps After 5G Approval Clears North America Sales Path

AmpliTech Jumps After 5G Approval Clears North America Sales Path

20 May 2026
AmpliTech received U.S. and Canadian certification for its full indoor 5G Native DAS hardware, enabling immediate commercial sales and integration across North America. Shares rose about 14% in premarket trading after the announcement. The company said it has orders from a North American mobile network operator, with shipments set to begin later this year.
Intuit’s Q3 Numbers Land as Shares Down 39%

Intuit’s Q3 Numbers Land as Shares Down 39%

20 May 2026
Intuit will report fiscal third-quarter results after U.S. markets close Wednesday, following a 39% stock drop over the past year. Analysts expect earnings of $12.57 per share on $8.54 billion revenue, both up from last year. The quarter covers peak tax season for TurboTax and QuickBooks. Intuit shares closed at $399.71 Tuesday, down 0.9%.
National Grid’s North Sea “GriffinLink” plan puts its share price back in focus
Previous Story

National Grid’s North Sea “GriffinLink” plan puts its share price back in focus

Lloyds share price today: LLOY.L ticks higher as sanctions fine fades and results loom
Next Story

Lloyds share price today: LLOY.L ticks higher as sanctions fine fades and results loom

Go toTop